Skip to main content
Skip to navigation
Skip to accessibility tools
Search bar
Mobile navigation
Return to main H&W ICS website
Search this site
Search
Close search bar
Home
About
About
Return to previous menu
About
Corporate
NHS Continuing Healthcare
Safeguarding
Board Members
Meetings
Meetings
Return to previous menu
Meetings
Board papers
Past meetings
Past Board Papers
News
Documents
Contact us
Contact us
Return to previous menu
Contact us
Stakeholder and Public Liaison and Information Team
Gastro-intestinal System
You are here:
Home
Documents
Clinical and Prescribing Policies, Guidance and Pathways
Gastro-intestinal System
Title
Rifaximin - Overt Hepatic Encephalopathy - Prescribing Guidance v1.1.1
Non Standard Surgery for Gastro Oesophageal Reflux Disease (GORD) - Position Statement v1.4
Inflammatory Bowel Disease Pathway v1.1
Hernia Surgery - Commissioning Policy v1.3
Haemorrhoid Treatment Position Statement v1.7
Gallstone & Gallbladder Disease Management - Commissioning Policy v1.9
Faecal Calprotectin testing for Suspected IBD or IBS - Commissioning Policy v1.4
Disease-Modifying Anti-Rheumatic (DMARD) - Shared Care Guidance v1.4
Appendicectomy Clinical Commissioning Position Statement v1.0
Back to Clinical and Prescribing Policies, Guidance and Pathways
Reducing health inequalities
Digital innovation
Health and care services
Get involved
Work for us
Latest news
Accessibility tools
Show accessibility tools
Text size:
Increase text size
Decrease text size
Reset text size
Contrast:
Black and white
Blue contrast
Beige contrast
High contrast
Reset contrast
Frank Ltd.
Return to header
Last accessibility toolbar action:
none available
